Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pharmacielo Ltd (OP: PCLOF )

0.1280 -0.0113 (-8.11%)
Streaming Delayed Price Updated: 3:49 PM EDT, Apr 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,323
Open 0.1280
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.1393
Today's Range 0.1259 - 0.1298
52wk Range 0.0801 - 0.2200
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
This Latin American Cannabis Co. Plans To Expand In Thailand Amid Significant Shifts In Weed Regulation Landscape
PharmaCielo revealed its plans to acquire cannabis operations in Thailand.On Wednesday, the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Can Cannabis Treat Severe Forms Of Epilepsy? New Medicine Sparks Hope As Colombia's Weed Industry Goes Global
Clever Leaves Holdings Inc. 
Via Benzinga
Topics Cannabis
Exposures Cannabis

Performance

YTD
-10.99%
-10.99%
1 Month
+35.16%
+35.16%
3 Month
-25.06%
-25.06%
6 Month
-31.18%
-31.18%
1 Year
-20.60%
-20.60%

More News

Read More
Cannabis Companies Partner To Provide Seed-to-Pharma Products Globally
Via Benzinga
Topics Cannabis
Exposures Cannabis
Top Cannabis Industry Leaders Who Took The Reins In 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Colombia's President Wants Weed Legalized Despite Senate Opposition: Prohibition Increases 'Profits Of Drug Trafficking, Violence'
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Extracts Producer PharmaCielo Narrows Loss, Cuts Expenses In Q3, CEO Projects Higher Profitability
Via Benzinga
Topics Cannabis
Exposures Cannabis
PharmaCielo Q2 2023 Results: Revenue Drops But CEO Is Optimistic About Future Growth
Via Benzinga
Topics Cannabis
Exposures Cannabis
Top Talent To Lead Two New US Marijuana Markets And Latest Key Hires In Cannabis Industry
Via Benzinga
PharmaCielo Q1 2023: Revenue Down 34.2% YoY, CEO Expects Robust Global Sales Of Cannabis Flower In 2023
Via Benzinga
PharmaCielo FY 2022 Revenue Grows 173%, What About Adjusted EBITDA?
Via Benzinga
PharmaCielo Layoffs And Voluntary Salary Reductions To Decrease Its Annualized Fixed Costs By ~25%
Via Benzinga
PharmaCielo Q3 Revenue Stagnates, What About Adjusted EBITDA?
Via Benzinga
PharmaCielo Ships Dried Cannabis Flower To The Czech Republic, Expanding Its Exports To EU
Via Benzinga
Update On Cannabis M&A: Aurora, TerrAscend, SNDL, Curaleaf, And... A Costly Preferred Stock Raise?
Via Benzinga
PharmaCielo Q2 Revenue Soars 375% YoY, Raises Additional $4.6M In Oversubscribed Debenture Financing
Via Benzinga
These 9 Cannabis Companies Are Leading The Way In Latin America: What Are They Up To And Why Should You Pay Attention?
Via Benzinga
PharmaCielo Makes First Shipment Of Cannabinoid Products To Mexican Joint Venture Partner
Via Benzinga
Strategic Cannabis Execs Making Changes At Companies You Know: PharmaCielo, Willow Industries, Delta 9 & More
Via Benzinga
PharmaCielo Signs Sales Agreement With Brazilian Phyto-Therapeutic Company
Via Benzinga
PharmaCielo Ships CBD Full Spectrum Oil To A Brazilian Pharmaceutical Company
Via Benzinga
PharmaCielo Q1 Revenue Increases 77.92% YoY, Discusses International Markets
Via Benzinga
PharmaCielo Enters Spanish Market With Initial Shipment Of 300Kg Of CBD Full Spectrum Oil To Extractions Solutions
Via Benzinga
PharmaCielo To Enter Polish Medical Cannabis Market Via Partnership With Soteria Holdings
Via Benzinga
Colombia's Flora Growth & PharmaCielo Begin Exporting Dried Flower As New Rules Take Effect
Via Benzinga
PharmaCeilo Inks First THC Salles Agreement, Will Suply Germany Via Greenstein And NOWEDA
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.